Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

autologous tumor infiltrating lymphocytes HV-101

A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from each patient's resected tumor and expanded ex vivo, with potential immunomodulating and antineoplastic activities. Upon administration back into the patient, autologous TILs HV-101 specifically recognize and kill the patient's tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:autologous TILs HV-101
autologous tumor-infiltrating lymphocytes HV-101
Code name:HV 101
HV-101
HV101
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search